Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dime Announces Appointment of Meyer Eichler as Executive Vice President, Managing Executive Director
Dime Announces Appointment of Meyer Eichler as Executive Vice President, Managing Executive Director
-
WASHINGTON, D.C., April 15, 2026 (GLOBE NEWSWIRE) -- The United States Mint (Mint) will begin accepting orders for the 2026 Semiquincentennial Emerging Liberty Dime Two-Roll Sets and Bags on April...
-
Enlace a Imágenes BROOKLYN, N.Y., April 15, 2026 (GLOBE NEWSWIRE) -- Hispanic Information and Telecommunication Network, Inc. (HITN), una organización estadounidense sin fines de lucro dedicada a...
-
Edye marks its 7th year as the leading Spanish-language preschool content platform for U.S. Hispanics and Latin America: safe, pedagogical, and joyful.
-
Dime Announces Significant Hires to Advance Growth Plan
-
HINGHAM, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it will...
-
Shareholder Notice: BellRing Brands (NYSE: BRBR); Coty (NYSE: COTY); e.l.f. Beauty (NYSE: ELF); and Power Solutions International (NASDAQ: PSIX)
-
HINGHAM, Mass., April 13, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced today that it has...
-
Dupixent de Sanofi et Regeneron approuvé dans l'UE comme premier médicament ciblé contre l'urticaire chronique spontanée chez les jeunes enfants L'approbation dans l'urticaire chronique spontanée...
-
Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria Approval in CSU for children two to 11 years of age is...